Who makes TIVA NoNarc?

TIVA NoNarc is developed by Coastal Anesthesiology Consultants.

What development phase is TIVA NoNarc in?

TIVA NoNarc is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

TIVA NoNarc

Coastal Anesthesiology Consultants · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	TIVA NoNarc
Sponsor	Coastal Anesthesiology Consultants
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Effect of Intraoperative Anesthetic Management on Postoperative Nausea and Vomiting in Bariatric Surgery (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

TIVA NoNarc CI brief — competitive landscape report
TIVA NoNarc updates RSS · CI watch RSS
Coastal Anesthesiology Consultants portfolio CI